-
-
-
-
-
-
-
Perrigo (PRGO) targets organic net sales CAGR of 2.5% to 4.5%
-
-
-
-
-
-
-
Perrigo Reports Second Quarter 2024 Financial Results From Continuing Operations
-
-
-
-
-
-
-
Perrigo Reports Second Quarter Fiscal Year 2023 Financial Results From Continuing Operations
-
-
-
-
-
-
-
Perrigo to Host Virtual Investor Day on February 28, 2023
-
-
-
-
-
-
-
PERRIGO TO RELEASE SECOND QUARTER 2022 FINANCIAL RESULTS ON AUGUST 9, 2022
-
-
-
-
-
-
-
PERRIGO ANNOUNCES U.S. FDA APPROVAL FOR OMEPRAZOLE MAGNESIUM DELAYED-RELEASE MINI CAPSULES
-
-
-
-
-
-
-
PERRIGO COMPLETES THE ACQUISITION OF HRA PHARMA
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

